S. 527Introduced
Prescription Pricing for the People Act of 2025
Require federal antitrust agencies to study and report on prescription drug pricing and competition in the pharmaceutical market
Plain-English overview
What this bill does
Require federal antitrust agencies to study and report on prescription drug pricing and competition in the pharmaceutical market
Key points
- Require drug pricing study
Current status
Where it stands
Status
Introduced
Latest action
2025-04-10 — Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.
Related context
Topics and policy areas
undefinedBusiness ethicsBusiness recordsCommerceCompetition and antitrustCongressional oversightConsumer affairsHealth care costs and insurance